News - Astellas Pharma, Anti-Arthritics/Rheumatics


Popular Filters

AbbVie/Eisai's Humira has best clinical profile among psoriatic arthritis treatments


Based on clinical data and the opinions of interviewed thought leaders interviewed by health care advisory…

AbbVieAnti-Arthritics/RheumaticsAstellas PharmaBiotechnologyCimziaEisaiEuropeHumiraMarkets & MarketingNorth AmericaPharmaceuticalUCB

Amgen and Astellas link up on drugs for unmet medical needs in Japan


World leading independent biotech firm Amgen (Nasdaq: AMGN) has joined forces with Japanese drug major…

AmgenAnti-Arthritics/RheumaticsAsia-PacificAstellas PharmaBiotechnologyCardio-vascularOncologyPharmaceuticalResearch

BioTrends views Xeljanz and Zytiga prescribing in USA


After around two months on the market, 37% of US rheumatologists have prescribed Pfizer's (NYSE: PFE)…

Anti-Arthritics/RheumaticsAstellas PharmaBiotechnologyJevtanaJohnson & JohnsonMedivationNorth AmericaOncologyPfizerPharmaceuticalSanofiXeljanzXtandiZytiga

Merck & Co in Nanobody deal with Ablynx; J&J and Astellas join forces on RA


US pharma giant Merck & Co (NYSE: MRK) has entered into a collaboration with Belgium's Ablynx (Euronext…

AblynxAnti-Arthritics/RheumaticsASPO15KAstellas PharmaBiotechnologyJohnson & JohnsonLicensingMerck & CoPharmaceutical

Eisai and Toyama's iguratimod, and Astellas' Gonax OKed in Japan


Japanese drug major Eisai (TYO: 4523) and Toyama Chemical have received approval from Japan's Ministry…

Anti-Arthritics/RheumaticsAsia-PacificAstellas PharmaCareramdegarelixEisaiFerring PharmaceuticalsGonaxiguratimodKolbetOncologyPharmaceuticalRegulationToyama

UCB links with Astellas for Cimzia in Japan


Following the recent discontinuation of a commercialization accord for its rheumatoid arthritis drug…

Anti-Arthritics/RheumaticsAsia-PacificAstellas PharmaCimziaLicensingPharmaceuticalUCB

EMA says risk-benefit of ARBs positive; acts on Advagraf and Protelos/Osseor


In a flurry of late news yesterday from the European Medicines Agency and its Committee for Medicinal…

AdvagrafAnti-Arthritics/RheumaticsAstellas PharmaCardio-vascularEuropeImmunologicalsPharmaceuticalProtelosRegulationServier

Teijin and Astellas expand collaboration on gout drug febuxostat


Japanese drugmakers Teijin Pharma (TYO: 3401 and Astellas Pharma (TKO:4503) have entered into an exclusive…

Anti-Arthritics/RheumaticsAsia-PacificAstellas PharmafebuxostatLicensingPharmaceuticalTeijin

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top